Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pichai Raman on behalf of cBioPortal Team Wednesday, May 25, 16

Similar presentations


Presentation on theme: "Pichai Raman on behalf of cBioPortal Team Wednesday, May 25, 16"— Presentation transcript:

1 Pichai Raman on behalf of cBioPortal Team Wednesday, May 25, 16
cBioPortal+ Cancer Visualization & Analytics Application for Research | Translational Science | Clinical Decisions Pichai Raman on behalf of cBioPortal Team Wednesday, May 25, 16

2 Outline History& Overview Data and Application usage
Key Functionality & Features Security & Authentication Coming Attractions

3 History & Overview Original cBioPortal developed at MSKCC for TCGA data and other large-scale cancer profiling efforts Lowers barrier to access and visualize complex genomic data for research cBioPortal Development now shared across 5 teams : DFCI, MSKCC, Princess Margaret, and CHOP, the Hyve cBioPortal+ : CHOP Implementation has a focus on Pediatric cancer data sets

4 History & Overview Excels at visualization & presentation of multiple data types in an integrated manner

5 Data and Application Usage
Used Extensively at MSKCC with > 5000 Users a week Type Total MSKCC CHOP Studies 113 91 22 Samples 24026 21334 2692 Data sets are being added on a weekly basis from various sources. Processed through reproducible best practice pipelines.

6 Data and Application Usage
MSKCC currently houses a number of data sources. Used Extensively at MSKCC with > 5000 Users a week SU2C CBTTC BUT WE ARE ADDING MORE TARGET EGA/dbGaP

7 Key Functionality & Features
cBioPortal+ has a number of visualizations based on one of three entry points Study View Display of frequent / recurrent mutations or lesions within a study When creating virtual co-horts of molecular subtypes will be able to quickly identify “potental” drivers Sample View Get an overview of all of a patients genetic lesions, connections to Path Reports, clinical trials, drugs, etc.. Has COSMIC data as well as internal statistics to aid in determining if a mutation is likely causal Gene View Look at gene data (mutation / expression etc..) across or within study Correlate genes to other genes within a study or compare to normal tissue expression Can be used to identify targets for immunotherapy

8 Key Functionality & Features
cBioPortal+ has a number of visualizations based on one of three entry points Study View Display of frequent / recurrent mutations or lesions within a study When creating virtual co-horts of molecular subtypes will be able to quickly identify “potental” drivers Sample View Get an overview of all of a patients genetic lesions, connections to Path Reports, clinical trials, drugs, etc.. Has COSMIC data as well as internal statistics to aid in determining if a mutation is likely causal Gene View Look at gene data (mutation / expression etc..) across or within study Correlate genes to other genes within a study or compare to normal tissue expression Can be used to identify targets for immunotherapy

9 Mutation Lollipop View Recurrent hotspot identification
Height indicates frequency Annotates with COSMIC, cBioPortal Frequencies, and predicts whether mutation event is damaing

10 Tumor vs Normal Immunotherapy Target Discovery
Color indicates significance P-value Cutoff P-value, Tumor vs Normal Median Tumor Expression Visualization for RNA-Seq or Microarray data, with ability to look at raw, log, or z-score normalizations and p-value showing differential

11 Other Gene View Visuals
Mutual Exclusivity Correlation PPI Networks

12 Key Functionality & Features
cBioPortal+ has a number of visualizations based on one of three entry points Study View Display of frequent / recurrent mutations or lesions within a study When creating virtual co-horts of molecular subtypes will be able to quickly identify “potental” drivers Sample View Get an overview of all of a patients genetic lesions, connections to Path Reports, clinical trials, drugs, etc.. Has COSMIC data as well as internal statistics to aid in determining if a mutation is likely causal Gene View Look at gene data (mutation / expression etc..) across or within study Correlate genes to other genes within a study or compare to normal tissue expression Can be used to identify targets for immunotherapy

13 Descriptive statistics on cohort
Summary Page Overview Recurrent CNV Recurrent Mutations Descriptive statistics on cohort

14 Selection of Samples Survival Plot
Select Genes and all samples with a mutation become a group for Survival Plot

15 Clinical Data Table Tabular view to find Samples
Clinical data sortable and searchable Can click on sample to get to sample view

16 Key Functionality & Features
cBioPortal+ has a number of visualizations based on one of three entry points Study View Display of frequent / recurrent mutations or lesions within a study When creating virtual co-horts of molecular subtypes will be able to quickly identify “potental” drivers Sample View Get an overview of all of a patients genetic lesions, connections to Path Reports, clinical trials, drugs, etc.. Has COSMIC data as well as internal statistics to aid in determining if a mutation is likely causal Gene View Look at gene data (mutation / expression etc..) across or within study Correlate genes to other genes within a study or compare to normal tissue expression Can be used to identify targets for immunotherapy

17 Clinical Trials and additional tabs
Patient Summary Page Add to Harvest Cart Mutation & CNA table Clinical Trials and additional tabs Genome View

18 Patient View Harvest Cart Integration
Clicking submit takes you to CBTTC Harvest application with desired samples loaded Samples Added to the bucket can be accessed via the HARVEST CART tab

19 Gene Target & FDA approval also listed
Patient View Drugs Tab Gene Target Gene Target & FDA approval also listed

20 Other Patient View Visuals
Tissue Images Pathology Report Clinical Data

21 Security & Authentication
User User Authentication Provided by Google Group CBTTC SU2C Public Data Set 1 Data Set 2 Data Set 3 Data Set 4 Data

22 Coming Attractions Timeline – Multiple samples per patient Support for PDX Variant Annotation & Prioritization More simplified clinical interface Isoform level information Connection to raw data and processing pipelines 30+ Active Developers from CHOP, MSKCC, DFCI, Princess Margeret, and the Hyve

23 Acknowledgements cBioPortal Consortium MSKCC DFCI Princess Margeret
The Hyve CBTTC Collaborators Adam Resnick Alex Felmeister Tyler Rivera Jena Lilly Angela Waanderers Philip Allman CHOP cBioPortal+ Team Karthik Kalletla Anna Lu Kaitlyn Money CHOP/DBHi Collaborators Deanne Taylor Asif Chinwalla John Maris & SU2C

24 Thank You Visit Us : Follow Us


Download ppt "Pichai Raman on behalf of cBioPortal Team Wednesday, May 25, 16"

Similar presentations


Ads by Google